NCT02900664 2022-03-29A Study of PDR001 in Combination With CJM112, EGF816, IlarisĀ® (Canakinumab) or MekinistĀ® (Trametinib)NovartisPhase 1 Completed283 enrolled
NCT00132704 2014-07-24An Analysis of the Response of Human Tumor Microvascular Endothelium to Ionizing RadiationMemorial Sloan Kettering Cancer CenterCompleted149 enrolled